OSR (OSRH) Competitors $0.52 +0.04 (+9.09%) As of 08/22/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesSEC FilingsTrendsBuy This Stock OSRH vs. NMTC, RBOT, ECOR, MODD, PSTV, POCI, CLGN, COCH, VVOS, and RVPShould you be buying OSR stock or one of its competitors? The main competitors of OSR include NeuroOne Medical Technologies (NMTC), Vicarious Surgical (RBOT), electroCore (ECOR), Modular Medical (MODD), Plus Therapeutics (PSTV), Precision Optics (POCI), CollPlant Biotechnologies (CLGN), Envoy Medical (COCH), Vivos Therapeutics (VVOS), and Retractable Technologies (RVP). These companies are all part of the "medical equipment" industry. OSR vs. Its Competitors NeuroOne Medical Technologies Vicarious Surgical electroCore Modular Medical Plus Therapeutics Precision Optics CollPlant Biotechnologies Envoy Medical Vivos Therapeutics Retractable Technologies OSR (NASDAQ:OSRH) and NeuroOne Medical Technologies (NASDAQ:NMTC) are both small-cap medical equipment companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Is OSRH or NMTC more profitable? OSR has a net margin of 0.00% compared to NeuroOne Medical Technologies' net margin of -55.44%. OSR's return on equity of -12.19% beat NeuroOne Medical Technologies' return on equity.Company Net Margins Return on Equity Return on Assets OSRN/A -12.19% -8.18% NeuroOne Medical Technologies -55.44%-163.49%-78.67% Which has more risk & volatility, OSRH or NMTC? OSR has a beta of 1.49, indicating that its share price is 49% more volatile than the S&P 500. Comparatively, NeuroOne Medical Technologies has a beta of 0.68, indicating that its share price is 32% less volatile than the S&P 500. Does the media favor OSRH or NMTC? In the previous week, NeuroOne Medical Technologies had 3 more articles in the media than OSR. MarketBeat recorded 4 mentions for NeuroOne Medical Technologies and 1 mentions for OSR. OSR's average media sentiment score of 1.05 beat NeuroOne Medical Technologies' score of 0.47 indicating that OSR is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OSR 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NeuroOne Medical Technologies 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals and insiders believe in OSRH or NMTC? 55.3% of OSR shares are owned by institutional investors. Comparatively, 16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. 33.7% of OSR shares are owned by company insiders. Comparatively, 8.9% of NeuroOne Medical Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has higher valuation and earnings, OSRH or NMTC? OSR has higher earnings, but lower revenue than NeuroOne Medical Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOSR$104.74K106.14-$2.41MN/AN/ANeuroOne Medical Technologies$3.45M11.37-$12.32M-$0.15-5.23 Do analysts prefer OSRH or NMTC? NeuroOne Medical Technologies has a consensus target price of $1.45, indicating a potential upside of 84.81%. Given NeuroOne Medical Technologies' stronger consensus rating and higher possible upside, analysts clearly believe NeuroOne Medical Technologies is more favorable than OSR.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OSR 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00NeuroOne Medical Technologies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryOSR beats NeuroOne Medical Technologies on 9 of the 14 factors compared between the two stocks. Get OSR News Delivered to You Automatically Sign up to receive the latest news and ratings for OSRH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OSRH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OSRH vs. The Competition Export to ExcelMetricOSRUNCLASSIFIED IndustryManufacturing SectorNASDAQ ExchangeMarket Cap$11.12M$179.77M$2.58B$9.76BDividend YieldN/AN/A2.54%4.06%P/E RatioN/A1.8922.0426.05Price / Sales106.1444.08274.2388.42Price / CashN/A74.4224.1559.36Price / Book0.08163.9031.916.60Net Income-$2.41M-$1.39M$31.01M$265.65M7 Day Performance-2.74%0.84%1.09%2.00%1 Month Performance-46.35%-3.77%1.17%0.46%1 Year PerformanceN/A92.53%28.72%18.88% OSR Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OSRHOSRN/A$0.52+9.1%N/AN/A$11.12M$104.74K0.00N/APositive NewsGap UpHigh Trading VolumeNMTCNeuroOne Medical Technologies2.6851 of 5 stars$0.82-1.2%$1.45+76.9%-4.2%$40.84M$3.45M-5.4620RBOTVicarious Surgical0.6416 of 5 stars$6.80-8.8%$7.00+2.9%-2.8%$40.68MN/A-0.67210ECORelectroCore1.9806 of 5 stars$5.24flat$25.50+386.6%-5.8%$39.70M$25.18M-3.2350MODDModular Medical0.2015 of 5 stars$0.72-2.3%N/A-59.1%$39.05MN/A-1.4120News CoveragePSTVPlus Therapeutics2.4302 of 5 stars$0.63+15.8%$10.83+1,625.3%-66.4%$37.98M$5.82M-0.2820Gap DownPOCIPrecision Optics0.1075 of 5 stars$4.67-1.3%N/A-7.7%$35.78M$19.10M-5.2580CLGNCollPlant Biotechnologies2.5959 of 5 stars$2.55-2.3%$11.50+351.0%-51.2%$32.42M$510K-2.0970News CoverageEarnings ReportAnalyst ForecastCOCHEnvoy Medical3.0294 of 5 stars$1.42-2.7%$9.25+551.4%-58.9%$30.56M$220K-0.9934Gap UpHigh Trading VolumeVVOSVivos Therapeutics1.2995 of 5 stars$4.11-10.8%$4.82+17.2%+55.3%$24.21M$15.03M-2.38160News CoverageEarnings ReportGap DownRVPRetractable Technologies1.8294 of 5 stars$0.80+2.6%N/A-13.8%$23.81M$33.75M-1.47240Positive News Related Companies and Tools Related Companies NeuroOne Medical Technologies Alternatives Vicarious Surgical Alternatives electroCore Alternatives Modular Medical Alternatives Plus Therapeutics Alternatives Precision Optics Alternatives CollPlant Biotechnologies Alternatives Envoy Medical Alternatives Vivos Therapeutics Alternatives Retractable Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OSRH) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?They said digital dollars were off the table. But with the GENIUS Act now federal law, private corporations—no...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OSR Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share OSR With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access